The Trump administration abandons its plan to limit discounts on drugs

The Trump administration is abandoning its plan to limit billions of dollars in annual drug rebate discounts to Medicare's middlemen, a move it says would reduce the price consumers pay for their prescription drugs.

This decision reflects months of tension between the White House and the Ministry of Health and Social Services over the proposal, which has also provoked a brutal response from drug benefit managers who manage drug programs. prescription drugs. It was a central element of President Trump's plan to reduce drug costs.

…